Skip to content
Biodatica
Start free

INSTITUTE FOR SYSTEMS BIOLOGY

SEATTLE, WA

Oncologycell therapyGrant-only
Compare Sign in to watch

What changed

NIH R01 · $1.2M · Preventing MAPK inhibitor resistance in melanoma by targeting genomic instability and immune resistance

5w agoGrant renewalJun 10, 2026Source filing (opens the source filing in a new tab)

Momentum

61no change

Momentum 61 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

9,925 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R01 · $647k · non-dilutive

    Mar 1, 2024

    UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LO, ROGER S · NCI · award ends Feb 28, 2029 · Melanoma Resistance Evolution Atlas (MREA) for identifying combinatorial targets to prevent and reverse MAPKi resistance

    NIH RePORTER · NIH RePORTER 11295389 (opens the source filing in a new tab)

  2. Grant

    U54 · $260k · non-dilutive

    Sep 22, 2022

    INSTITUTE FOR SYSTEMS BIOLOGY · PI LO, ROGER S · NCI · award ends Aug 31, 2027 · Core 1: Mouse Model and Tissue Biobank Core

    NIH RePORTER · NIH RePORTER 11191436 (opens the source filing in a new tab)

  3. Grant

    R01 · $1.2M · non-dilutive

    Sep 4, 2013

    UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LO, ROGER S · NCI · award ends Jun 30, 2029 · Preventing MAPK inhibitor resistance in melanoma by targeting genomic instability and immune resistance

    NIH RePORTER · NIH RePORTER 11360720 (opens the source filing in a new tab)

  4. Grant

    P20 · $214k · non-dilutive

    Sep 30, 2001

    UNIV OF ARKANSAS FOR MED SCIS · PI TACKETT, ALAN · NIGMS · award ends Apr 30, 2031 · Research Technology Core

    NIH RePORTER · NIH RePORTER 11091160 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources